Company Overview
VANDA PHARMACEUTICALS INC.
VNDARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
216M
2025 FY
Net Income
-220M
2025 FY
Shares Outstanding
59M
2025 FY
EPS
-3.74USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1347178
Exchange
Nasdaq
Location
US